insert_link Health / Medical Lenacapavir shows 96% HIV prevention success A six-monthly HIV prevention injection containing lenacapavir has been confirmed effective in two pivotal studies. The first study, PURPOSE 1, showed no HIV infections among two-thousand-134 participants, while the second, PURPOSE 2, reported two infections among two-thousand-179 participants. This translates to a 96-percent reduction in HIV infections compared to background incidence. Gilead Sciences plans to file for regulatory approval to market lenacapavir for prevention. Separately, during a press briefing on Monday, the U.S. Department […] todayOctober 15, 2024 46
insert_link Namibia Project HOPE Namibia launches USD60 million ANAPA Project in Malawi to tackle HIV crisis among young adults and children Namibia in Malawi (PHN-MA) proudly announces the recent official launch of the Ana ndi Achinyamata Patsogolo – ANAPA (Children and Youth First) initiative in response to the ongoing challenges posed by HIV among young adults and children in the country. The HIV epidemic in Malawi presents a significant challenge, particularly impacting vulnerable groups such as children, adolescents, and young women. Despite progress towards UNAIDS goals fueled […] todayJune 14, 2024 423